Research by Zeng et al. [35] revealed that downregulating S100A9 led to the upregulation of E-cadherin in HPC cells and reversed their cisplatin resistance, suggesting that S100A9 induces chemotherapy tolerance in tumor cells by promoting EMT. This evidence concerns the gene S100A9 and neoplasm.